EDITORIAL SECTION

Articles

Top 5 Pharma Content Formats That Drive Engagement and Leads

The pharmaceutical business is experiencing a significant change in the way it informs the healthcare professionals decisionmakers and business partners Conventional means of promotion is no longer sufficient in a context whereby buyers do a lot of research before involving themselves with vendors Consequently pharma content marketing has turned out to be a vital instrument of establishing credibi...

Innovative Solutions: Cell and Gene Therapy's Impact on Pharma

Cell therapy involves the use of living cells to treat medical conditions These cells can be sourced from a patient or a donor and are often manipulated or engineered to enhance their therapeutic effects

The Next Growth Strategy: Scaling GLP-1 Manufacturing and Global Market Expansion

For most of the past four years the strategic conversation around GLP receptor agonists was a demand story Prescriptions outran forecasts waiting lists formed pharmacy shelves emptied and the commercial debate centred on reimbursement prescriber behaviour and how far the obesity indication could stretch That conversation has changed Demand for incretin therapies is now the most predictable variabl...

Implementing Quality by Design (QbD) in Pharmaceutical Development: Enhancing Product Quality and Regulatory Compliance

Quality by Design QbD stands as a systematic strategy for pharmaceutical development prioritizing predefined product objectives and emphasizing a thorough understanding of both the product and its manufacturing processes This proactive approach integrates quality seamlessly into the development process championing a sciencedriven

The Unprecedented Surge of Biopharmaceuticals in the European Market

Recent years have seen a significant upheaval in the European pharmaceutical scene marked by an unparalleled surge in biopharmaceutical prominence This shift isnt fleeting but signifies a profound and enduring transformation To fully grasp this paradigm shift its essential to explore the complex interplay of scientific advancements market dynamics regulatory frameworks economic factors and global...

Combination Immunotherapy Trials: Designing the Next Generation of Cancer Drugs

For most of the past ten years the prevailing strategy in immunooncology was addition Checkpoint blockade delivered durable remissions in a minority of patients the intuitive fix was to attach a second agent to a PD or PDL backbone and watch whether response rates moved

Techno Trends

USF Researchers Identify New P. vivax Vaccine Target

Researchers at USF Health have identified a previously unknown vulnerability in Plasmodium vivax a major malaria parasite found across parts of Asia and Central and South America

Projects

Evonik Launches US$94 Million (EUR 80 million) Biotechnology Expansion in Slovakia

Evonik has commenced construction of a new biotechnology expansion at its Fermas facility in Slovensk upa Slovakia The development is part of an approximately US million investment EUR million

Research Insights

One-month physicochemical stability study of idarubicin prepared in polyolefin-type bags for the treatment of hematological diseases

Idarubicine is a mainstay of the treatment strategy for hematological cancer The literature lacks stability data that comply with current preparation practices and recommendations for conducting stability studies

whitepaper

Post-Translational Modifications in Drug Discovery: From Molecular Regulation to Clinical Impact

For decades the central dogma of molecular biology has anchored our understanding of cellular function DNA to RNA to protein But this linear view is incomplete A growing body of evidence shows that much of biologys